Results showed that doxorubicin exposure resulted in decreases in cell viability and increases in apoptotic cells and expressions of cleaved PARP and cleaved caspase-3 in BC and BC-DoxR cells (Figure S2-S4). The gene discussed is CASP3; the disease is breast cancer.